Company profile
Devonian Health Group Inc.
OTC: DVHGF · Healthcare · Biotechnology
Canadian filerHQ Québec, QCReports USD
#608 of 1,417 Healthcare companies by revenue34th-percentile growth
EA Score
46DFH 48DQ —GM 48SS 29
v0.1 · 45/100 weight · provisional
↑ 3-yr revenue growth, operating margin · ↓ Piotroski F, listing tenure
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
-91.5%
Net income (FY)
-$3.1M
Employees
8
as of 2026-08-21
Market cap
$19.5M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$12.2M17.0M CAD2025
Net income-$3.1M-4.3M CAD2025
Operating income-$736.4k-1.0M CAD2025
Total assets$8.3M11.4M CAD2025
Liabilities$4.8M6.7M CAD2025
Equity$4.8M6.6M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Devonian Health Group Inc.’s revenue?
Devonian Health Group Inc. booked $12.2M in FY2025 revenue, contracting 6.9% year over year — slower than 66% of Healthcare companies we track, at a -25.5% net margin.
Peers · Healthcare
Medical Marijuana, Inc.58CEmmaus Life Sciences, Inc.40DElutia Inc52DPrelude Therapeutics Incorporated37DEscalon Medical Corp.63CBIMI International Medical Inc.——Key facts
CEOAndre Boulet
SectorHealthcare
IndustryBiotechnology
HeadquartersQuébec, QC
ExchangeOTC: DVHGF
Employees8
IPO date2022-09-19
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.